Endosialin Expression in Metastatic Melanoma Tumor Microenvironment Vasculature: Potential Therapeutic Implications.
about
Novel antibody probes for the characterization of endosialin/TEM-1.Endosialin and Associated Protein Expression in Soft Tissue Sarcomas: A Potential Target for Anti-Endosialin Therapeutic Strategies.A phase 2 study of ontuxizumab, a monoclonal antibody targeting endosialin, in metastatic melanoma.Phase 1 trial of ontuxizumab (MORAb-004) in children with relapsed or refractory solid tumors: A report from the Children's Oncology Group Phase 1 Pilot Consortium (ADVL1213).
P2860
Endosialin Expression in Metastatic Melanoma Tumor Microenvironment Vasculature: Potential Therapeutic Implications.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Endosialin Expression in Metas ...... tial Therapeutic Implications.
@ast
Endosialin Expression in Metas ...... tial Therapeutic Implications.
@en
Endosialin Expression in Metas ...... tial Therapeutic Implications.
@nl
type
label
Endosialin Expression in Metas ...... tial Therapeutic Implications.
@ast
Endosialin Expression in Metas ...... tial Therapeutic Implications.
@en
Endosialin Expression in Metas ...... tial Therapeutic Implications.
@nl
prefLabel
Endosialin Expression in Metas ...... tial Therapeutic Implications.
@ast
Endosialin Expression in Metas ...... tial Therapeutic Implications.
@en
Endosialin Expression in Metas ...... tial Therapeutic Implications.
@nl
P2093
P2860
P1433
P1476
Endosialin Expression in Metas ...... ntial Therapeutic Implications
@en
P2093
Daniel J O'Shannessy
Eiji Kiyohara
Elizabeth B Somers
James S Wilmott
Ling Takeshima
Nicholas Donovan
Peter Jones
Sharon Huang
P2860
P2888
P304
P356
10.1007/S12307-015-0168-8
P577
2015-06-18T00:00:00Z
P5875
P6179
1045899429